5-(1-环己烯-1-基)-3-[(反式-4-甲氧基环己基)[( 反式-4-甲基环己基)羰基]氨基]噻吩-2-羧酸钾盐

• 常用名: 5-(1-环己烯-1-基)-3-[(反式-4-甲氧基环己基)[( 反式-4-甲基环己基)羰基]氨基]噻吩-2-羧酸钾盐
• 英文名: VCH-916
• CAS号: 1200133-34-1
• 分子量: 497.732
• 密度: N/A
• 沸点: N/A
• 分子式: C₂₆H₃₆KNO₄S
• 熔点: N/A
• 闪点: N/A

用途

VCH-916是非核苷类HCV NS5B聚合酶抑制剂。

名称

• 中文名: 5-(1-环己烯-1-基)-3-[(反式-4-甲氧基环己基)[( 反式-4-甲基环己基)羰基]氨基]噻吩-2-羧酸钾盐
• 英文名: potassium,5-(cyclohexen-1-yl)-3-[(4-methoxycyclohexyl)-(4-methylcyclohexanecarbonyl)amino]thiophene-2-carboxylate

生物活性

• 描述: VCH-916是非核苷类HCV NS5B聚合酶抑制剂。
• 相关类别:
  信号通路 >> 代谢酶/蛋白酶 >> HCV蛋白酶
  信号通路 >> 抗感染 >> HCV
  研究领域 >> 感染
• 参考文献:

  [1]. Ludmila Gerber, Tania M. Welzel, Stefan Zeuzem. New therapeutic strategies in HCV: polymerase inhibitors. Liver International. 2013,33(s1): 85-92

  [2]. Abdelrahman S. Mayhoub. Hepatitis C RNA-dependent RNA polymerase inhibitors: A review of structure-activity and resistance relationships; different scaffolds and mutations. Bioorganic & Medicinal Chemistry. 2012, 20 (10): 3150-3161.

  [3]. Debasis Dasa, Jian Honga, Shu-Hui Chena, et al. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry. 2011, 19(16): 4690-4703

  [4]. Pierre L Beaulieu. Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection. Informahealthcare. 2009, 19(2): 145-164

  [5]. Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection

物理化学性质

• 分子式: C₂₆H₃₆KNO₄S
• 分子量: 497.732
• 精确质量: 497.200226
• PSA: 97.91000
• LogP: 5.18590
• 储存条件: 2-8℃

英文别名

• S1493_Selleck
• CS-1224
• Potassium 5-(1-cyclohexen-1-yl)-3-{(trans-4-methoxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino}-2-thiophenecarboxylate
• VCH 916
• 2-Thiophenecarboxylic acid, 5-(1-cyclohexen-1-yl)-3-[(trans-4-methoxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]-, potassium salt (1:1)
• VCH-916||VCH 916
• VCH-916